{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:39:32Z","timestamp":1790631572280,"version":"4.1.0"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.ahj.2022.06.005","type":"journal-article","created":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T01:43:51Z","timestamp":1655516631000},"page":"20-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Rationale for and design of a multicenter, placebo-controlled, phase 3 study to assess efficacy and safety of intranasal etripamil for the conversion of paroxysmal supraventricular tachycardia"],"prefix":"10.1016","volume":"253","author":[{"given":"Bruce S.","family":"Stambler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Plat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip T.","family":"Sager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Lubkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Shardonofsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Wight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. John","family":"Camm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ahj.2022.06.005_bib0001","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1056\/NEJMcp051145","article-title":"Clinical practice. Supraventricular tachycardia","volume":"354","author":"Delacr\u00e9taz","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2022.06.005_bib0002","series-title":"Clinical arrhythmology and electrophysiology: a companion to Braunwald's heart disease","author":"Issa","year":"2012"},{"key":"10.1016\/j.ahj.2022.06.005_bib0003","series-title":"Cardiac rhythms and arrhythmias. Electrophysiological disorders of the heart","first-page":"249","article-title":"Chapter 14. Paroxysmal supraventricular tachycardias and the preexcitation syndromes","author":"Saksena","year":"2005"},{"key":"10.1016\/j.ahj.2022.06.005_bib0004","first-page":"e506","volume":"133","author":"Page","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2022.06.005_bib0005","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1161\/01.CIR.0000059743.36226.E8","article-title":"Contemporary management of paroxysmal supraventricular tachycardia","volume":"107","author":"Ferguson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2022.06.005_bib0006","unstructured":"Ip JE, Wight D, Seng Yue C, et\u00a0al. Pharmacokinetics and pharmacodynamics of etripamil, an intranasally administered, fast-acting, non-dihydropyridine calcium channel blocker. Manuscript in preparation."},{"key":"10.1016\/j.ahj.2022.06.005_bib0007","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jacc.2018.04.082","article-title":"Etripamil nasal spray for rapid conversion of supraventricular tachycardia to sinus rhythm","volume":"72","author":"Stambler","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2022.06.005_bib0008","first-page":"1200","article-title":"Etripamil nasal spray for acute termination of spontaneous episodes of paroxysmal supraventricular tachycardia. NODE-301 trial","volume":"17","author":"Stambler","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ahj.2022.06.005_bib0009","unstructured":"E9(R1) Statistical principles for clinical trials: Addendum: Estimands and sensitivity analysis in clinical trials. 2021. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/e9r1-statistical-principles-clinical-trials-addendum-estimands-and-sensitivity-analysis-clinical. Accessed May 26, 2022."},{"key":"10.1016\/j.ahj.2022.06.005_bib0010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1477-7525-7-36","article-title":"Validation of an abbreviated treatment satisfaction questionnaire for medication (TSQM-9) among patients on antihypertensive medications","volume":"7","author":"Bharmal","year":"2009","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.ahj.2022.06.005_bib11","unstructured":"Stambler BS, Plat F, Sager PT, et al. The first randomized, multicenter, placebo-controlled study of self-administered 2 intranasal etripamil for acute conversion of spontaneous paroxysmal supraventricular 3 tachycardia (NODE-301), Circulation: Arrhythmia and Electrophysiology, Submitted for publication."}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870322001296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870322001296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:08:50Z","timestamp":1757570930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870322001296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":11,"alternative-id":["S0002870322001296"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2022.06.005","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationale for and design of a multicenter, placebo-controlled, phase 3 study to assess efficacy and safety of intranasal etripamil for the conversion of paroxysmal supraventricular tachycardia","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2022.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}